not tagged
not tagged
[]
biosimilar multi-switching in ra: is it an issue? switching back &amp; forth between originator &amp; biosimilar should create ideal conditions for immunogenicity or anti-drug ab this study: multi-switching vs no switching
no issues at all switch away in ra! abst1589 #acr22 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own